Showing results (171-180 of 222) with videos related to
Sort By:
Pageof 23
Antioxidants (Basel, Switzerland)|September 28, 2021
Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney InjuryKranti A Mapuskar, Emily J Steinbach, Amira Zaher, et al.Radiation Research|July 4, 2013
Low-dose radiation-induced enhancement of thymic lymphomagenesis in Lck-Bax mice is dependent on LET and genderJames A Jacobus, Chester G Duda, Mitchell C Coleman, et al.Nature|August 21, 2020
Lymph protects metastasizing melanoma cells from ferroptosisJessalyn M Ubellacker, Alpaslan Tasdogan, Vijayashree Ramesh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cellsNadire Duru, Ming Fan, Demet Candas, et al.Molecular and Cellular Biology|March 18, 2003
Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responsesGuozheng Guo, Yan Yan-Sanders, Beverly D Lyn-Cook, et al.Journal of Oncology Translational Research|December 17, 2016
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung CancerAmir Zahra, Tangel Chang, Taher Abu Hejleh, et al.Oncogene|September 6, 2002
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiationShervin Karimpour, Junyang Lou, Lilie L Lin, et al.Cancer Research|August 3, 2017
Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and ChemotherapyKranti A Mapuskar, Kyle H Flippo, Joshua D Schoenfeld, et al.Biorxiv : the Preprint Server for Biology|May 22, 2023
Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as well as Inhibiting SCLC Xenograft GrowthSpenser S Johnson, Dijie Liu, Jordan T Ewald, et al.Radiation Research|November 21, 2023
Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine CancersMelissa A Fath, Dijie Liu, Jordan T Ewald, et al.Pageof 23